Exosomal microRNA-25 secreted by cancer-associated fibroblasts promotes the metastasis of esoph-ageal carcinoma cells
Sang Yonghua,Yang Wentao,Wang Yifei,Xue Xiang,Xu Xuejun,Chen Yongbing,Zhang Wenya
DOI: https://doi.org/10.3760/cma.j.cn421213-20211125-01341
2022-01-01
Abstract:Objective:To analyze the expression of minichromosome maintenance protein 8 (MCM8) in esophagus carcinoma (ESCA) and its correlations with the prognosis and impacts on the tumor microenvironments (TME) of ESCA.Methods:MRNA values of MCM8 in ESCA, adjacent tumor, esophageal squamous epithelium, Barrett’s esophageal (BE) tissues were obtained from the Gene Expression Omnibus (GEO) database, then analyzed by t tests. UALCAN was used to study the expression of MCM8 in different stages and grades of ESCA patients enrolled in the The Cancer Genome Atlas (TCGA) database. We collected 6 samples from ESCA patients hospitalized at the Affiliated Hospital of Yangzhou University and the surgical therapy was given from January to March 2022. Immunohistochemical staining (IHC) was used to verify the protein expression of MCM8. Kaplan-meier Plotter database was used to analyze the correlations between MCM8 and the prognosis of ESCA. MCM8 co-expressing genes in ESCA were obtained from cBio-portal, and the possible mechanisms were explored by DAVID enrichment analysis. MCM8 protein interaction networks were performed by STRING and PINA databases. Correlations between MCM8 and infiltrating levels of immune cells in ESCA TME were analyzed by non-parameter tests with TISIDB database. Results:The MRNA expression of MCM8 from datasets GSE161533, GSE45670 in ESCA (47.36±17.59, 660.30±282.00) was upregulated as compared with the adjacent tumor tissues (22.89±4.30, 293.90±125.90, t=7.15, 4.13, P<0.01). MRNA level of MCM8 in the low-differentiated group (16.40) was higher than the medium and high differentiated ESCA groups (12.84, 8.77, P<0.05). MCM8 mRNA expression of GSE77563 in BE tissue (5.12±1.13) was upregulated compared to the esophageal squamous epithelial tissues (3.99±0.55, t=4.26, P<0.01). IHC demonstrated that MCM8 was upregulated in ESCA compared to adjacent tissues (the MCM8-positive integral optical density/area value of para-cancerous tissue was normalized to 1, then the value of positive cancer tissues was 2.35±0.17, t=19.74, P<0.01). Upregulated MCM8 was related with the short overall survival rate ( P<0.01). Enrichment analysis showed that MCM8 may be involved in the regulation of cell cycle, RNA transport, DNA mismatch repair. MCM8 was closely related to the molecules from the cell division control protein and origin recognition complex families. MCM8 was negatively correlated with the infiltration of activated T cells, natural killer cells and dendritic cells in ESCA TME ( r=-0.23, -0.22, -0.254, respectively, P<0.05). Conclusion:We demonstrated that MCM8 was upregulated in ESCA and showed strong correlations with the progression, prognosis and immune infiltration of ESCA. MCM8 may be a potential therapeutic target for ESCA.